Proteomic analysis identifies adenine nucleotide translocase 3 (ANT3) as an interacting protein of HSPA9 and indicates that HSPA9 can disrupt the interaction between ANT3 and cyclophilin D (CypD) in BRAF mutant cancer cells (Fig. 3) [106]. This evidence concerns the gene HSPA9 and cancer.